Literature DB >> 10583409

Striatum- and testis-specific phosphodiesterase PDE10A isolation and characterization of a rat PDE10A.

K Fujishige1, J Kotera, K Omori.   

Abstract

PDE10A, a phosphodiesterase (PDE) exhibiting properties of a cAMP PDE and a cAMP-inhibited cGMP PDE, was cloned and investigated in detail in rats. PDE10A transcripts were abundant in the brain and testis. In situ hybridization analysis using a PDE10A riboprobe demonstrated the presence of PDE10A transcripts in the neurons of the striatum and the olfactory tubercle regions of the brain. Rat PDE10A cDNAs were isolated from a brain cDNA library and nucleotide sequence analysis revealed several N-terminal variants. The deduced amino-acid sequence of one of the major variant forms contained 794 amino acids, and it was 96% identical to that of the human PDE10A2. The other major form has a distinct N-terminal sequence that is not found in humans. PDE10A was partially purified from rat striatum and testis, and characterized with respect to Km, inhibitor sensitivity and immunoreactivity to an anti-PDE10A serum. These findings indicate that PDE10A functions in these tissues.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10583409     DOI: 10.1046/j.1432-1327.1999.00963.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  37 in total

Review 1.  TAK-063, a novel PDE10A inhibitor with balanced activation of direct and indirect pathways, provides a unique opportunity for the treatment of schizophrenia.

Authors:  Kazunori Suzuki; Haruhide Kimura
Journal:  CNS Neurosci Ther       Date:  2018-01-09       Impact factor: 5.243

Review 2.  Cyclic nucleotide phosphodiesterases as targets for treatment of haematological malignancies.

Authors:  Adam Lerner; Paul M Epstein
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

3.  Cellular and subcellular localization of PDE10A, a striatum-enriched phosphodiesterase.

Authors:  Z Xie; W O Adamowicz; W D Eldred; A B Jakowski; R J Kleiman; D G Morton; D T Stephenson; C A Strick; R D Williams; F S Menniti
Journal:  Neuroscience       Date:  2006-02-17       Impact factor: 3.590

4.  Inhibition of Phosphodiesterase 10A Increases the Responsiveness of Striatal Projection Neurons to Cortical Stimulation.

Authors:  Sarah Threlfell; Stephen Sammut; Frank S Menniti; Christopher J Schmidt; Anthony R West
Journal:  J Pharmacol Exp Ther       Date:  2008-12-04       Impact factor: 4.030

5.  Discovery of novel PDE10 inhibitors by a robust homogeneous screening assay.

Authors:  Qun-yi Li; Ming-kai Xu; Gang Liu; Claus Tornby Christoffersen; Ming-wei Wang
Journal:  Acta Pharmacol Sin       Date:  2013-04-22       Impact factor: 6.150

6.  Carbon-11 labeled papaverine as a PET tracer for imaging PDE10A: radiosynthesis, in vitro and in vivo evaluation.

Authors:  Zhude Tu; Jinbin Xu; Lynne A Jones; Shihong Li; Robert H Mach
Journal:  Nucl Med Biol       Date:  2010-03-06       Impact factor: 2.408

7.  Manipulation of olfactory tight junctions using papaverine to enhance intranasal delivery of gemcitabine to the brain.

Authors:  Mansi Krishan; Gary A Gudelsky; Pankaj B Desai; Mary Beth Genter
Journal:  Drug Deliv       Date:  2013-10-14       Impact factor: 6.419

8.  Phosphodiesterase 10A Is Tethered to a Synaptic Signaling Complex in Striatum.

Authors:  Corina Russwurm; Doris Koesling; Michael Russwurm
Journal:  J Biol Chem       Date:  2015-03-11       Impact factor: 5.157

Review 9.  The role of phosphodiesterases in schizophrenia : therapeutic implications.

Authors:  Judith A Siuciak
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

10.  Nitric oxide-soluble guanylyl cyclase signaling regulates corticostriatal transmission and short-term synaptic plasticity of striatal projection neurons recorded in vivo.

Authors:  Stephen Sammut; Sarah Threlfell; Anthony R West
Journal:  Neuropharmacology       Date:  2009-12-05       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.